- Home
- DLPN vs RDHL Comparison
DLPN vs RDHL Comparison
Compare DLPN & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLPN
- RDHL
- Stock Information
- Founded
- DLPN 1996
- RDHL 2009
- Country
- DLPN United States
- RDHL Israel
- Employees
- DLPN 269
- RDHL N/A
- Industry
- DLPN Other Consumer Services
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- DLPN Consumer Discretionary
- RDHL Health Care
- Exchange
- DLPN Nasdaq
- RDHL Nasdaq
- Market Cap
- DLPN 16.2M
- RDHL 3.9M
- IPO Year
- DLPN N/A
- RDHL N/A
- Fundamental
- Price
- DLPN $1.24
- RDHL $1.69
- Analyst Decision
- DLPN Strong Buy
- RDHL
- Analyst Count
- DLPN 1
- RDHL 0
- Target Price
- DLPN $5.00
- RDHL N/A
- AVG Volume (30 Days)
- DLPN 74.6K
- RDHL 43.1K
- Earning Date
- DLPN 11-13-2025
- RDHL 09-05-2025
- Dividend Yield
- DLPN N/A
- RDHL N/A
- EPS Growth
- DLPN N/A
- RDHL N/A
- EPS
- DLPN N/A
- RDHL N/A
- Revenue
- DLPN $51,257,243.00
- RDHL $9,550,000.00
- Revenue This Year
- DLPN $9.05
- RDHL $381.91
- Revenue Next Year
- DLPN $15.42
- RDHL N/A
- P/E Ratio
- DLPN N/A
- RDHL N/A
- Revenue Growth
- DLPN 4.84
- RDHL 157.62
- 52 Week Low
- DLPN $0.75
- RDHL $1.06
- 52 Week High
- DLPN $1.78
- RDHL $11.70
- Technical
- Relative Strength Index (RSI)
- DLPN 52.80
- RDHL 63.60
- Support Level
- DLPN $1.14
- RDHL $1.47
- Resistance Level
- DLPN $1.21
- RDHL $1.71
- Average True Range (ATR)
- DLPN 0.07
- RDHL 0.09
- MACD
- DLPN 0.01
- RDHL 0.05
- Stochastic Oscillator
- DLPN 41.33
- RDHL 98.98
About DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.